Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
advances in neurology
adverse drug reaction
akathisia
albumin
alcohol
alcoholism
alpha-synuclein
alternative medicine
Alzheimer's disease
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, prognosis
amyotrophic lateral sclerosis, treatment of
aneurysm
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
angiotensin II receptor blocker
antibiotics
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antihypertensive
antioxidant
apolipoprotein E
apoptosis
aptiganel
arm weakness
ascorbic acid
aspirin
atherosclerosis, generalized
autonomic dysfunction
axonal degeneration
biologic markers
BiPAP
blacks
blood pressure
body temperature
brain atrophy
brain transplantation
bulbar palsy
bulbar palsy, progressive
burning paresthesia
caffeine
calcium antagonist
calcium antagonist, side effects of
cardiac arrest
cardiac arrest and resuscitation
caspases
CAT scan
CAT scan, abnormal
CAT scan, disappearing lesion on
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, xenon-enhanced
cerebral blood flow
cerebral edema
cerebral embolism
cerebral infarction
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, complications with
cerebrovascular accident, neonatal
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, spontaneous improvement after
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of presentation
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, surgical treatment of
cholesterol
cholesterol, LDL
cigarette smoking
citicoline
clinical trials
cognition
coma
controversies in neurology
cooling therapy
coronary artery disease
craniectomy, decompressive
crying, pathologic
DATATOP study
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, incidence
dementia, prevention of
dementia, treatment of
deprenyl
diabetes mellitus
diet
dimebon
disability, neurological
distal muscle weakness
dopamine agonist
dopamine receptor, D2
drug induced neurologic disorders
dying
dysarthria
dyskinesia, buccal lingual facial
dysphagia
efficacy
embolism
emergencies, neurologic
emergency medical technicians
emotional lability
encephalopathy, post traumatic
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endarterectomy, carotid-long term results
endarterectomy, carotid-morbidity and mortality with
endovascular therapy
enzyme inhibition
epidemiology of neurology
excitotoxin
fasciculation
fatigue
fever
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibroblast growth factor
fish
flavonoids
foot drop
free radical
fruits
fumarate
gadolinium
gender
Glasgow coma score
glutamic acid
head injury
head injury, evaluation of
head injury, management of
head injury, pathophysiology of
head injury, prevention
head injury, prognosis in
headache
headache, treatment of
hemodilution
hemorrhage, intracranial, newborn
hemorrhage, periventricular
heparin
heralding manifestation
herpes simplex encephalitis, diagnosis of
histamine-2 receptor blockers
HMGcoA reductase inhibitors
hormone replacement
hospice
hydrocephalus
hyperreflexia
hypertension
hyperthermia
hyperuricemia
hypotension, systemic
hypothermia
hypoxic encephalopathy
iatrogenic neurologic disorders
ibuprofen
immunomodulation
indomethacin
intellectual deficit
intracranial pressure monitoring
intraventricular hemorrhage
intrinsic hand muscles, wasting of
ischemic penumbra
Kleine-Levin syndrome
lacunar infarction
laughing, pathologic
L-dopa
leg weakness, unilateral
Lewy body
Lewy body disease, diffuse
life expectancy
lipid lowering agent
lithium
low birth weight
lubeluzole
magnesium sulfate
melatonin
mental status, evaluation of
middle cerebral artery, occlusion of
migraine, prophylaxis
migraine, treatment of
mild cognitive impairment
minocycline
monoamine oxidase inhibitors
mortality
motor neuron disease
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRS
multiple sclerosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle wasting, diffuse
N-acetyl-L-aspartic acid
nerve growth factor
neuroendocrinology
neurologic disease
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination
neurologic symptoms
neurologic testing
neuronal cell death
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotransmitter
nicardipine
nimodipine
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
old age, neurology of
pallidotomy
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinsonism syndrome
pathology
pineal
piracetam
platelet inhibiting drugs
practice guidelines
pravastatin
preclinical
premarin
prevention of neurologic disorders
prognosis
psychological testing
rasagiline
rehabilitation for neurologic disorders
research
respirator
respiratory failure
review article
riluzole
risk factors
risk-benefit assessment
safety
seizure
seizure, treatment of
simvastatin
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
sodium-glucoe cotransporter-2 inhibitors
statin therapy
stimulant drugs
streptokinase
stroke unit
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
tea
tetracycline
thrombolysis, mechanical
tissue plasminogen activator, intravenous
treatment of neurologic disorder
tremor, thalamic stimulation for suppression of
tripping
vasospasm, cerebral
vegetables
vestibular function, tests of
vitamin A
vitamin D
vitamin E
vitamin supplementation
whites
wine
Showing articles 1450 to 1500 of 3460 << Previous Next >>

Intravenous r-TPA in Vertebrobasilar Acute Infarcts
Neurol 62:1854-1856, Montavont,A.,et al, 2004

Vasculitic Mononeuritis Multiplex Induced by Valcyclovir
Neurol 62:1906-1907, Pary,L.F.,et al, 2004

Recurrent Meningitis of Unknown Aetiology
Lancet 363:1772, Ellerin,T.B.,et al, 2004

Clinical and Radiological Predictors of Recanalisation and Outcome of 40 Patients with acute Basilar Artery Occlusion Treated with Intra-Arterial Thrombolysis
JNNP 75:857-862, Arnold,M.,et al, 2004

Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage
Stroke 35:1360-1364, Woo,D.,et al, 2004

Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004

Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004

Methylprednisolone, Valacyclovir, or the Combination for Vestibular Neuritis
NEJM 351:354-361,322, Strupp,M.,et al, 2004

Chemotherapy as Initial Treatment in Gliomatosis Cerebri
Neurol 63:354-356, Levin,N.,et al, 2004

Initial Chemotherapy in Gliomatosis Cerebri
Neurol 63:270-275,204, Sanson,M.,et al, 2004

Prediction of Hospital Disposition After Thrombolysis for Acute Ischemic Stroke Using the National Institutes of Health Stroke Scale
Arch Neurol 61:1061-1064, Schlegel,D.J.,et al, 2004

Peripheral Neuropathy
Lancet 363:2151-2161, England,J.D. &Asbury,A.K., 2004

Remote Evaluation of Acute Ischemic Stroke in Rural Community Hospitals in Georgia
Stroke 35:1763-1768, Wang,S.,et al, 2004

Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004

Gadolinium-Enhanced CT Angiography of the Circle of Willis and Neck
AJNR 25:969-972, Henson,J.W.,et al, 2004

The Clinical-DWI Mismatch
Neurol 62:2187-2192, Davalos,A.,et al, 2004

Thalidomide Sensory Neurotoxicity
Neurol 62:2291-2293, Cavaletti,G.,et al, 2004

Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004

Naturally Acquired West Nile Virus Encephalomyelitis in Transplant Recipients
Arch Neurol 61:1210-1220, Kleinschmidt-DeMasters,B.K.,et al, 2004

Hallucinations During Methylphenidate Therapy
Neurol 63:753-754, Gross-Tsur,V.,et al, 2004

Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004

Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004

Salvage Therapy for Primary CNS Lymphoma with a Combination of Rituximab and Temozolomide
Neurol 63:901-903, Enting,R.H.,et al, 2004

Recent Developments in Bell's Palsy
BMJ 329:553-557, Holland,N.J. & Weiner,G.M., 2004

Bell's Palsy
NEJM 351:1323-1331, Gilden,D.H., 2004

Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004

Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004

Expanding the Range of Therapies for Acute Ischemic Stroke: The Early Experience of the Regional Stroke Center at Hartford Hospital
Connecticut Medicine 68:419-429, Silvernman,I.E.,et al, 2004

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004

Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004

Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004

Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004

Long-Term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
JAMA 292:1862-1866, Lindsberg,P.J.,et al, 2004

Thrombolytic Therapy in Stroke-Related Trauma
Conn Med 68:551-553, Finelli,P.F. &Beland,D., 2004

Tacrolimus Leukoencephalopathy: A Neuropathologic Confirmation
Neurol 63:1132-1133, Lavigne,C.M.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
NEJM 351:2170-2178, Alexandrov,A.V.,et al, 2004

Clomipramine Induced Neuroleptic Malignant Syndrome and Pyrexia of Unknown Origin
BMJ 329:1333-1335, Haddow,A.M.,et al, 2004

Rheolytic Catheter Thrombectomy, Balloon Angioplasty, and Direct Recombinant Tissue Plasminogen Activator Thrombolysis of Dural Sinus Thrombosis with Preexisting Hemorrhagic Infarctions
AJNR 25:1807-1811, Curtin,K.R.,et al, 2004

Access to Intra-Arterial Therapies for Acute Ischemic Stroke: An Analysis of the US Population
AJNR 25:1802-1806, Suzuki,S.,et al, 2004

Acute Methotrexate Neurotoxicity: Findings on Diffusion-Weighted Imaging and Correlation with Clinical Outcome
AJNR 25:1688-1695, Rollins,N.,et al, 2004

Thrombolysis for Acute Ischemic Stroke
Stroke 35:2914-2915, Wardlaw,J.,et al, 2004

Statins in Stroke Prevention and Carotid Artherosclerosis, Systematic Review and Up-to-Date Meta-Analysis
Stroke 35:2902-2909, Amarenco,P.,et al, 2004

Incidence of Hospitalized Rhabdomyloysis in Patients Treated With Lipid-Lowering Drugs
JAMA 292:2585-2590, Graham,D.J.,et al, 2004

Statin-Associated Exacerbation of Myasthenia Gravis
Neurol 63:2188, Cartwright,M.S.,et al, 2004

Cerebral Toxoplasmosis in a Patient with Common Variable Immunodeficiency
Neurol 63:2192-2193, Holtkamp,M.,et al, 2004

Clinicopath Conf, Malignant Middle Cerebral Artery Infarction
NEJM 350:707-716, Case 5-2004, 2004

Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004



Showing articles 1450 to 1500 of 3460 << Previous Next >>